EPIAXIS THERAPEUTICS
EpiAxis Therapeutics is pursuing a preclinical and clinical drug development program directed at the prevention of metastatic disease by targeting the pivotal enzyme system controlling the proliferation of cancer stem cells (CSC). Specifically, that target is the nuclear bound lysine-specific demethylase 1 (LSD1) & its upstream regulator, the theta isoform of protein kinase C (PKC theta). The research identifying this target and the intellectual property (IP) that resulted from this was develope... d by Professor Sudha Rao and colleagues at the University of Canberra (UC), Australia. The Company is focused initially on the prevention of metastatic breast cancer, with other CSC mediated diseases such as ovarian, pancreatic, colon, melanoma, lung and liver cancers to be pursued later. EpiAxis is positioning itself to become the leading cancer recurrence prevention company with its proprietary LSD1 & PKC theta inhibitors included in the standard of care (SoC) for cancer.
EPIAXIS THERAPEUTICS
Social Links:
Industry:
Biotechnology
Address:
Canberra, Australian Capital Territory, Australia
Country:
Australia
Website Url:
http://www.epiaxistherapeutics.com
Status:
Active
Contact:
+61 421 012 268
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Domain Not Resolving Wordpress Plugins
Similar Organizations
RNADerm Therapeutics
RNADerm Therapeutics is a biotechnology company.
Current Employees Featured
Official Site Inspections
http://www.epiaxistherapeutics.com Semrush global rank: 5.93 M Semrush visits lastest month: 1.39 K
- Host name: cp53.hosting-cloud.net
- IP address: 103.119.110.60
- Location: India
- Latitude: 20.0063
- Longitude: 77.006
- Timezone: Asia/Kolkata